Target intelligence / Profile preview

Promoting blood circulation to remove blood stasis

Molecular classification
Therapeutic strategy, Traditional Chinese Medicine (TCM) pharmacological principle
01

Overview

"Promoting blood circulation to remove blood stasis" (Huoxue Huayu) is a fundamental therapeutic principle in Traditional Chinese Medicine (TCM) rather than a single molecular target. It describes a pharmacological strategy aimed at treating "Blood Stasis Syndrome," a pathological state characterized by impaired blood flow, vascular obstruction, and microcirculatory disturbances. This approach encompasses a broad range of biological activities, including the inhibition of platelet activation, modulation of the coagulation cascade, and enhancement of fibrinolytic activity. Modern research has identified that medicinal herbs and compounds associated with this principle act on multiple targets such as thrombin, cyclooxygenase-1 (COX-1), and vascular endothelial growth factor (VEGF). Clinically, this strategy is widely applied in the management of cardiovascular and cerebrovascular diseases, chronic inflammatory conditions, and certain types of pain and fibrosis.

Other names
Huoxue HuayuActivating blood and resolving stasisInvigorating blood and removing blood stasisBlood-activating and stasis-resolvingPromoting blood flow and eliminating blood stasis
02

Mechanism of action

Multi-target regulation of hemodynamics, including inhibition of platelet glycoprotein IIb/IIIa receptors, reduction of plasma viscosity, promotion of nitric oxide release for vasodilation, and inhibition of inflammatory cytokine expression.

03

Biological functions

AnticoagulationAnti-platelet aggregationFibrinolysisVasodilationMicrocirculation improvementAnti-inflammation
04

Disease associations

Cardiovascular diseaseCerebrovascular diseaseThrombosisAngina pectorisMyocardial infarctionStrokeFibrosis
05

Safety considerations

Increased risk of hemorrhage or bleedingDrug-herb interactions with clinical anticoagulants (e.g., Warfarin, Heparin)Interaction with antiplatelet agents (e.g., Aspirin, Clopidogrel)Contraindicated during pregnancyPotential for menorrhagia
06

Interacting drugs

Salvia miltiorrhiza (Danshen)

5 more in the full profile.

07

Biomarkers

D-dimerPlatelet aggregation rateFibrinogen levelsProthrombin time (PT)Activated partial thromboplastin time (aPTT)Whole blood viscosity

Beyond the preview

Go deeper on Promoting blood circulation to remove blood stasis.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Promoting blood circulation to remove blood stasis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call